Scroll Top

Implementation science approaches to promote ocular gene therapy into medical care

Implementation science approaches to promote ocular gene therapy into medical care
Implementation science approaches to promote ocular gene therapy into medical care

Implementation science approaches to promote ocular gene therapy into medical care

The “Implementation science approaches to promote ocular gene therapy into medical care” project will enhance the long-standing relationship that the Centre for Eye Research Australia (CERA) has with the University of Melbourne.

Project Overview:

Industry Researcher PhD candidate Fleur O’Hare will undertake an innovative project to develop a framework for Australian institutes to deliver ocular gene therapy. Under the supervision of A/Prof Lauren Ayton, Dr. Thomas Edwards and Prof Keith Martin this project dives deep into regulatory, organisational, clinician, and patient preparedness, aggregating data and dissecting barriers/enablers. The goal? An evidence-based model supporting the Australian healthcare system in implementing ocular gene therapy, expanding capacity, and establishing a sustainable model for sight-saving treatments. Expected outcomes include enhanced capacity and capability for ocular gene therapy delivery, shaping a sustainable model for long-term impact.

Privacy Preferences
When you visit our website, it may store information through your browser from specific services, usually in form of cookies. Here you can change your privacy preferences. Please note that blocking some types of cookies may impact your experience on our website and the services we offer.